drugset / Trial / NCT02643823
Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis
Phase 1
Unknown
40 enrolled
Shenzhen Hornetcorn Bio-technology Company, LTD
Futian People's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC) for Rheumatoid Arthritis.
Timeline
- Start
- 2016-01
- Primary completion
- 2017-01
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 2e+07 cells | Intravenous |
| Comparator | Methotrexate | Small molecule | — | — |